This specific ISBN edition is currently not available.View all copies of this ISBN edition:
The age of Biotech is dawning, says BusinessWeek. Here's how companies will benefit from the coming revolution in biotechnology. Biotech companies are quickly becoming the new economic engines of growth and innovationand when they explode, the Internet revolution will look like small potatoes. Businesses must prepare now for the post-information Biotech Age, and this is the book that will get them ready.Richard Oliver, author of the acclaimed The Shape of Things to Come, has created the first practical guide to the Biotech Age. Rather than focusing on science or social issues, he presents an accessible overview of the business of biotechnology and its vast implications and opportunities for all types of industries. Like the Internet, this is a topic few can afford to miss out onespecially future-minded executives and investors in cutting-edge technologies.
"synopsis" may belong to another edition of this title.
Thanks to the impending completion of the human genome project and related endeavors, virtually everyone agrees, biotechnology will have as much economic and social impact on the start of the new century as the Internet had on the end of the last one. But Richard Oliver, a Vanderbilt professor and former marketing executive, makes even that prediction look restrained, as he broadens the playing field and assesses the future in The Coming Biotech Age. Focusing on what he calls "bioterials," Oliver provocatively projects nothing but good times from developments in biology and advanced materials--which encompasses technologies and businesses "whose aim is to understand, alter, or direct the function of a wide set of organic cells, including plant, animal, and human," as well as those "aimed at 'conquering' inorganic materials" likewise to meet commercial needs. Some may find the book too one-sided, as Oliver generally glosses over opposition to the revolution by simply dismissing those who challenge its inevitability or possibilities. Readers comfortable with this proselytizing position, however, will immediately pick up on his enthusiasm and grow to believe (as Oliver does) that this is the story of the 21st century. --Howard RothmanFrom the Back Cover:
Biotechnology and its social and economic implications have been hotly debated in the pages of the popular press from The Wall Street Journal to Time Magazine, as well as on the nightly news. In fact, according to Richard W. Oliver, biotech and its commercial applicationsbioterialswill surpass the Information Age as the new engine of the economy. "By the middle of the 21st century, all companies will be bioterial companies," predicts Oliver. "The bioterials economy will grow faster, be more global, more pervasive and more powerful than any model before it."
An essential discussion to the future of business, The Coming Biotech Age describes the biotech revolution taking place within our leading universities, corporations and government. Without daunting scientific jargon, Oliver reveals what everyone CESs, investors, policymakers and others interested in the social ramifications of bioterials must know, for instance:
*How the biotech lab is becoming a GeneFactory with the mass production of healthcare products and agricultural biotech
*How the Bioterial Age will fundamentally alter the laws of economics as we know them
*How biotechnology is changing the actual structure of the corporation
Oliver also takes a look at the biovisionaries researchers, scientists and business leaders behind the biotech movement, and the biocapitalists who are poised to cash in on the new era.
A unique focus of The Coming Biotech Age is the positive effects that biotech will have on the global economy. Global chemical suppliers (DuPont, Novatis, Monsanto) are reinventing themselves as biotech firms, joining over 4000 biotechnology organizations around the world. while Oliver does discuss potential dangers of biotechnologies, he also points out the tremendous advances biotech has brought:
*Over 100 million people worldwide have been helped by the development of new biotechnology products and vaccines.
*Hundreds of biotechnology products and vaccines currently in human clinical trials and the hundreds more in early development with the potential to help millions more
In The Coming Biotech Age you'll read about these remarkable bioterial developments: pharmaceuticals tailored to an individual's genetic makeup ... babies made healthy through genetic modification ... pest- and disease-resistant food ... "smart" materials that mimic human processes ... endless solar energy machines... and many more. Oliver places these developments within an economic context, explaining what these advances will mean to the global business community.
The potential for bioterials is tremendousand infinite. If you're in business you cannot afford to miss The Coming Biotech Age. Truly, your company's future will depend on it.
"I've been deep inside the biotech industry since its infancy. This book provides fresh insights about how it started, what drives it, and most importantly, where it's going."
Scott W. Morrison, Partner, Ernst & Young LLP.
"Timely insights into an industry about to emerge as the single most important driver of the 21st century; knowledge-based economy with breakthrough discoveries that will yield unprecedented advances in our battle to combat disease and benefit humankind."
Dr. Francesco Bellini, CEO, BioChem Pharma.
"Every business leader must be thinking about the potential transformation from 'e-commerce' to bioterial commerce!"
James Harper, President, Diabetes and Growth Products, Eli Lilly & Co.
"A readable, timely, forward-looking and provocative book. A must read for anyone interested to understand, or profit from, an industry that will change the dynamics of our economy in the 21st century."
Alicia Loffer, Ph.D., Director, Northwestern University, Center for Biotechnology
"Anyone who speculates about the future (and who among us doesn't ) must arm themselves with the perspectives in Oliver's provocative look at the next twenty years."
John C. Sorenson, President, Novartis Seeds, Inc.
"A remarkably astute overview, both balanced and informative, of how the rapid evolution of biotechnology is paving the way for bioterials."
Joyce Groote, President, BIOTECanada.
"About this title" may belong to another edition of this title.
Book Description McGraw-Hill 1999-11-26, 1999. Hardcover. Condition: New. 0071350209 BRAND NEW. A portion of your purchase of this book will be donated to non-profit organizations. Over 1,000,000 satisfied customers since 1997! We ship daily M-F. Choose expedited shipping (if available) for much faster delivery. Delivery confirmation on all US orders. Seller Inventory # Z0071350209ZN
Book Description McGraw-Hill Companies, 1999. Hardcover. Condition: New. Seller Inventory # DADAX0071350209
Book Description McGraw-Hill, 1999. Condition: New. book. Seller Inventory # M0071350209
Book Description Condition: New. NEW. Seller Inventory # MOSE A17